MEETMUSA | Accelerating the iMpact of microsurgEry by upscaling production of thE world’s first microsurgical roboT: MUSA

Summary
The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company is introducing MUSA, the world’s first clinically available CE-certified microsurgical robot. We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers. The MUSA robot is highly efficient thereby reducing costs and improving access to microsurgical procedures. With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes. In this project, we will tackle the remaining bottlenecks for succesful outroll of the product including upscaling and optimizing manufacturability, to allow for rapid market uptake of MUSA after the project. MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190126849
Start date: 01-01-2022
End date: 30-04-2024
Total budget - Public funding: 2 637 708,75 Euro - 1 814 022,00 Euro
Cordis data

Original description

The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company is introducing MUSA, the world’s first clinically available CE-certified microsurgical robot. We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers. The MUSA robot is highly efficient thereby reducing costs and improving access to microsurgical procedures. With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes. In this project, we will tackle the remaining bottlenecks for succesful outroll of the product including upscaling and optimizing manufacturability, to allow for rapid market uptake of MUSA after the project. MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.

Status

SIGNED

Call topic

HORIZON-EIC-2021-ACCELERATOROPEN-01

Update Date

09-02-2023
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
EU-Programme-Call
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.2 The Accelerator
HORIZON-EIC-2021-ACCELERATOROPEN-01 EIC Accelerator Open 2021